Loading…
Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia
Prefrontal serotonin 2A receptors (5‐HT2ARs) have been linked to the pathogenesis and treatment of schizophrenia. Many antipsychotics fully occupy 5‐HT2AR at clinical relevant doses, and activation of 5‐HT2A receptors by lysergic acid diethylamide (LSD) and LSD‐like drugs induces a schizophrenia‐lik...
Saved in:
Published in: | Journal of neuroscience research 2013-05, Vol.91 (5), p.634-641 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4248-ab6353dbc113c4a9a06802201c042b6c623b43008953580d560aaaac03d1dae43 |
---|---|
cites | cdi_FETCH-LOGICAL-c4248-ab6353dbc113c4a9a06802201c042b6c623b43008953580d560aaaac03d1dae43 |
container_end_page | 641 |
container_issue | 5 |
container_start_page | 634 |
container_title | Journal of neuroscience research |
container_volume | 91 |
creator | Santini, Martin A. Ratner, Cecilia Aznar, Susana Klein, Anders B. Knudsen, Gitte M. Mikkelsen, Jens D. |
description | Prefrontal serotonin 2A receptors (5‐HT2ARs) have been linked to the pathogenesis and treatment of schizophrenia. Many antipsychotics fully occupy 5‐HT2AR at clinical relevant doses, and activation of 5‐HT2A receptors by lysergic acid diethylamide (LSD) and LSD‐like drugs induces a schizophrenia‐like psychosis in humans. Subchronic phencyclidine (PCP) administration is a well‐established model for schizophrenia‐like symptoms in rodents. The aim of the present study was to investigate whether subchronic PCP administration changes expression, binding, or functionality of cortical 5‐HT2ARs. As a measure of 5‐HT2AR functionality, we used the 5‐HT2AR agonist 2,5‐dimethoxy‐4‐iodoamphetamine (DOI)‐induced head‐twitch response (HTR) and mRNA expression of the immediate‐early genes (IEGs) activity‐related cytoskeletal associated‐protein (Arc), c‐fos, and early growth response protein 2 (egr‐2) in the frontal cortex. Mice were treated with PCP (10 mg/kg) or saline for 10 days, followed by a 5‐day washout period. The PCP pretreatment increased the overall induction of HTR and frontal cortex IEG mRNA expression following a single challenge with DOI. These functional changes were not associated with changes in 5‐HT2AR binding. Also, binding of the 5‐HT1AR and the 5‐HT transporter was unaffected. Finally, basal mRNA level of Arc was increased in the prefrontal cortex after subchronic PCP administration as revealed with in situ hybridization. Together these findings indicate that PCP administration produces changes in the brain that result in an increase in the absolute effect of DOI. Therefore, neurotransmission involving the 5‐HT2AR could contribute to the behavioral deficits observed after PCP treatment. © 2013 Wiley Periodicals, Inc. |
doi_str_mv | 10.1002/jnr.23198 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1434033394</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1434033394</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4248-ab6353dbc113c4a9a06802201c042b6c623b43008953580d560aaaac03d1dae43</originalsourceid><addsrcrecordid>eNqNkUFv1DAQhS0EokvhwB9AlrjAIe3Y4zjJsV2V0qpqRQXiaDmOt_GStYOdCJZfj9tte0CqhA_jw3zvyX6PkLcMDhgAP1z7eMCRNfUzsmDQVIUoRfWcLAAlFAIY3yOvUloDQNOU-JLscRQgRIMLMp74XntjOzpGu4rBT3qgycYwBe885Uc0WmPHKUSa3I3Xg_M3NC-m3tI0t6bPEmfo2FtvtmZwnfOWbsKcbmdnBxpWNJne_QljH613-jV5sdJDsm_u733y7dPJ1-Xn4uLq9Gx5dFEYwUVd6FZiiV1rGEMjdKNB1sA5MAOCt9JIjq1AgDp_qKyhKyXofAxgxzptBe6TDzvfMYafs02T2rhk7DBob_PzFBM5A0Rs_gNFJqFErGVG3_-DrsMccyx3VCWaGkuWqY87ysSQUs5VjdFtdNwqBuq2MZUbU3eNZfbdvePcbmz3SD5UlIHDHfDLDXb7tJM6v7x-sCx2Cpcm-_tRoeMPJSusSvX98jSLj6-_lMeNWuJfHG6uXQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1317498351</pqid></control><display><type>article</type><title>Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Santini, Martin A. ; Ratner, Cecilia ; Aznar, Susana ; Klein, Anders B. ; Knudsen, Gitte M. ; Mikkelsen, Jens D.</creator><creatorcontrib>Santini, Martin A. ; Ratner, Cecilia ; Aznar, Susana ; Klein, Anders B. ; Knudsen, Gitte M. ; Mikkelsen, Jens D.</creatorcontrib><description>Prefrontal serotonin 2A receptors (5‐HT2ARs) have been linked to the pathogenesis and treatment of schizophrenia. Many antipsychotics fully occupy 5‐HT2AR at clinical relevant doses, and activation of 5‐HT2A receptors by lysergic acid diethylamide (LSD) and LSD‐like drugs induces a schizophrenia‐like psychosis in humans. Subchronic phencyclidine (PCP) administration is a well‐established model for schizophrenia‐like symptoms in rodents. The aim of the present study was to investigate whether subchronic PCP administration changes expression, binding, or functionality of cortical 5‐HT2ARs. As a measure of 5‐HT2AR functionality, we used the 5‐HT2AR agonist 2,5‐dimethoxy‐4‐iodoamphetamine (DOI)‐induced head‐twitch response (HTR) and mRNA expression of the immediate‐early genes (IEGs) activity‐related cytoskeletal associated‐protein (Arc), c‐fos, and early growth response protein 2 (egr‐2) in the frontal cortex. Mice were treated with PCP (10 mg/kg) or saline for 10 days, followed by a 5‐day washout period. The PCP pretreatment increased the overall induction of HTR and frontal cortex IEG mRNA expression following a single challenge with DOI. These functional changes were not associated with changes in 5‐HT2AR binding. Also, binding of the 5‐HT1AR and the 5‐HT transporter was unaffected. Finally, basal mRNA level of Arc was increased in the prefrontal cortex after subchronic PCP administration as revealed with in situ hybridization. Together these findings indicate that PCP administration produces changes in the brain that result in an increase in the absolute effect of DOI. Therefore, neurotransmission involving the 5‐HT2AR could contribute to the behavioral deficits observed after PCP treatment. © 2013 Wiley Periodicals, Inc.</description><identifier>ISSN: 0360-4012</identifier><identifier>EISSN: 1097-4547</identifier><identifier>DOI: 10.1002/jnr.23198</identifier><identifier>PMID: 23404493</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>AIDS-Related Complex - genetics ; AIDS-Related Complex - metabolism ; Amphetamines - pharmacology ; Analysis of Variance ; Animals ; Autoradiography ; Disease Models, Animal ; Gene Expression Regulation - drug effects ; Gene Expression Regulation - physiology ; Genes, Immediate-Early - genetics ; immediate early genes ; Male ; Mice ; Mice, Inbred C57BL ; N-methyl-D-aspartate ; Phencyclidine - pharmacology ; Phencyclidine - toxicity ; prefrontal cortex ; Prefrontal Cortex - drug effects ; Prefrontal Cortex - metabolism ; Proto-Oncogene Proteins c-fos - genetics ; Proto-Oncogene Proteins c-fos - metabolism ; Receptors, Serotonin, 5-HT2 - metabolism ; RNA, Messenger - metabolism ; schizophrenia ; Schizophrenia - chemically induced ; Schizophrenia - pathology ; Serotonin Receptor Agonists - pharmacology ; serotoninergic receptors ; Signal Transduction - drug effects ; Time Factors</subject><ispartof>Journal of neuroscience research, 2013-05, Vol.91 (5), p.634-641</ispartof><rights>Copyright © 2013 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4248-ab6353dbc113c4a9a06802201c042b6c623b43008953580d560aaaac03d1dae43</citedby><cites>FETCH-LOGICAL-c4248-ab6353dbc113c4a9a06802201c042b6c623b43008953580d560aaaac03d1dae43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23404493$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Santini, Martin A.</creatorcontrib><creatorcontrib>Ratner, Cecilia</creatorcontrib><creatorcontrib>Aznar, Susana</creatorcontrib><creatorcontrib>Klein, Anders B.</creatorcontrib><creatorcontrib>Knudsen, Gitte M.</creatorcontrib><creatorcontrib>Mikkelsen, Jens D.</creatorcontrib><title>Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia</title><title>Journal of neuroscience research</title><addtitle>J. Neurosci. Res</addtitle><description>Prefrontal serotonin 2A receptors (5‐HT2ARs) have been linked to the pathogenesis and treatment of schizophrenia. Many antipsychotics fully occupy 5‐HT2AR at clinical relevant doses, and activation of 5‐HT2A receptors by lysergic acid diethylamide (LSD) and LSD‐like drugs induces a schizophrenia‐like psychosis in humans. Subchronic phencyclidine (PCP) administration is a well‐established model for schizophrenia‐like symptoms in rodents. The aim of the present study was to investigate whether subchronic PCP administration changes expression, binding, or functionality of cortical 5‐HT2ARs. As a measure of 5‐HT2AR functionality, we used the 5‐HT2AR agonist 2,5‐dimethoxy‐4‐iodoamphetamine (DOI)‐induced head‐twitch response (HTR) and mRNA expression of the immediate‐early genes (IEGs) activity‐related cytoskeletal associated‐protein (Arc), c‐fos, and early growth response protein 2 (egr‐2) in the frontal cortex. Mice were treated with PCP (10 mg/kg) or saline for 10 days, followed by a 5‐day washout period. The PCP pretreatment increased the overall induction of HTR and frontal cortex IEG mRNA expression following a single challenge with DOI. These functional changes were not associated with changes in 5‐HT2AR binding. Also, binding of the 5‐HT1AR and the 5‐HT transporter was unaffected. Finally, basal mRNA level of Arc was increased in the prefrontal cortex after subchronic PCP administration as revealed with in situ hybridization. Together these findings indicate that PCP administration produces changes in the brain that result in an increase in the absolute effect of DOI. Therefore, neurotransmission involving the 5‐HT2AR could contribute to the behavioral deficits observed after PCP treatment. © 2013 Wiley Periodicals, Inc.</description><subject>AIDS-Related Complex - genetics</subject><subject>AIDS-Related Complex - metabolism</subject><subject>Amphetamines - pharmacology</subject><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Autoradiography</subject><subject>Disease Models, Animal</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Gene Expression Regulation - physiology</subject><subject>Genes, Immediate-Early - genetics</subject><subject>immediate early genes</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>N-methyl-D-aspartate</subject><subject>Phencyclidine - pharmacology</subject><subject>Phencyclidine - toxicity</subject><subject>prefrontal cortex</subject><subject>Prefrontal Cortex - drug effects</subject><subject>Prefrontal Cortex - metabolism</subject><subject>Proto-Oncogene Proteins c-fos - genetics</subject><subject>Proto-Oncogene Proteins c-fos - metabolism</subject><subject>Receptors, Serotonin, 5-HT2 - metabolism</subject><subject>RNA, Messenger - metabolism</subject><subject>schizophrenia</subject><subject>Schizophrenia - chemically induced</subject><subject>Schizophrenia - pathology</subject><subject>Serotonin Receptor Agonists - pharmacology</subject><subject>serotoninergic receptors</subject><subject>Signal Transduction - drug effects</subject><subject>Time Factors</subject><issn>0360-4012</issn><issn>1097-4547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqNkUFv1DAQhS0EokvhwB9AlrjAIe3Y4zjJsV2V0qpqRQXiaDmOt_GStYOdCJZfj9tte0CqhA_jw3zvyX6PkLcMDhgAP1z7eMCRNfUzsmDQVIUoRfWcLAAlFAIY3yOvUloDQNOU-JLscRQgRIMLMp74XntjOzpGu4rBT3qgycYwBe885Uc0WmPHKUSa3I3Xg_M3NC-m3tI0t6bPEmfo2FtvtmZwnfOWbsKcbmdnBxpWNJne_QljH613-jV5sdJDsm_u733y7dPJ1-Xn4uLq9Gx5dFEYwUVd6FZiiV1rGEMjdKNB1sA5MAOCt9JIjq1AgDp_qKyhKyXofAxgxzptBe6TDzvfMYafs02T2rhk7DBob_PzFBM5A0Rs_gNFJqFErGVG3_-DrsMccyx3VCWaGkuWqY87ysSQUs5VjdFtdNwqBuq2MZUbU3eNZfbdvePcbmz3SD5UlIHDHfDLDXb7tJM6v7x-sCx2Cpcm-_tRoeMPJSusSvX98jSLj6-_lMeNWuJfHG6uXQ</recordid><startdate>201305</startdate><enddate>201305</enddate><creator>Santini, Martin A.</creator><creator>Ratner, Cecilia</creator><creator>Aznar, Susana</creator><creator>Klein, Anders B.</creator><creator>Knudsen, Gitte M.</creator><creator>Mikkelsen, Jens D.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201305</creationdate><title>Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia</title><author>Santini, Martin A. ; Ratner, Cecilia ; Aznar, Susana ; Klein, Anders B. ; Knudsen, Gitte M. ; Mikkelsen, Jens D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4248-ab6353dbc113c4a9a06802201c042b6c623b43008953580d560aaaac03d1dae43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>AIDS-Related Complex - genetics</topic><topic>AIDS-Related Complex - metabolism</topic><topic>Amphetamines - pharmacology</topic><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Autoradiography</topic><topic>Disease Models, Animal</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Gene Expression Regulation - physiology</topic><topic>Genes, Immediate-Early - genetics</topic><topic>immediate early genes</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>N-methyl-D-aspartate</topic><topic>Phencyclidine - pharmacology</topic><topic>Phencyclidine - toxicity</topic><topic>prefrontal cortex</topic><topic>Prefrontal Cortex - drug effects</topic><topic>Prefrontal Cortex - metabolism</topic><topic>Proto-Oncogene Proteins c-fos - genetics</topic><topic>Proto-Oncogene Proteins c-fos - metabolism</topic><topic>Receptors, Serotonin, 5-HT2 - metabolism</topic><topic>RNA, Messenger - metabolism</topic><topic>schizophrenia</topic><topic>Schizophrenia - chemically induced</topic><topic>Schizophrenia - pathology</topic><topic>Serotonin Receptor Agonists - pharmacology</topic><topic>serotoninergic receptors</topic><topic>Signal Transduction - drug effects</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Santini, Martin A.</creatorcontrib><creatorcontrib>Ratner, Cecilia</creatorcontrib><creatorcontrib>Aznar, Susana</creatorcontrib><creatorcontrib>Klein, Anders B.</creatorcontrib><creatorcontrib>Knudsen, Gitte M.</creatorcontrib><creatorcontrib>Mikkelsen, Jens D.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Santini, Martin A.</au><au>Ratner, Cecilia</au><au>Aznar, Susana</au><au>Klein, Anders B.</au><au>Knudsen, Gitte M.</au><au>Mikkelsen, Jens D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia</atitle><jtitle>Journal of neuroscience research</jtitle><addtitle>J. Neurosci. Res</addtitle><date>2013-05</date><risdate>2013</risdate><volume>91</volume><issue>5</issue><spage>634</spage><epage>641</epage><pages>634-641</pages><issn>0360-4012</issn><eissn>1097-4547</eissn><abstract>Prefrontal serotonin 2A receptors (5‐HT2ARs) have been linked to the pathogenesis and treatment of schizophrenia. Many antipsychotics fully occupy 5‐HT2AR at clinical relevant doses, and activation of 5‐HT2A receptors by lysergic acid diethylamide (LSD) and LSD‐like drugs induces a schizophrenia‐like psychosis in humans. Subchronic phencyclidine (PCP) administration is a well‐established model for schizophrenia‐like symptoms in rodents. The aim of the present study was to investigate whether subchronic PCP administration changes expression, binding, or functionality of cortical 5‐HT2ARs. As a measure of 5‐HT2AR functionality, we used the 5‐HT2AR agonist 2,5‐dimethoxy‐4‐iodoamphetamine (DOI)‐induced head‐twitch response (HTR) and mRNA expression of the immediate‐early genes (IEGs) activity‐related cytoskeletal associated‐protein (Arc), c‐fos, and early growth response protein 2 (egr‐2) in the frontal cortex. Mice were treated with PCP (10 mg/kg) or saline for 10 days, followed by a 5‐day washout period. The PCP pretreatment increased the overall induction of HTR and frontal cortex IEG mRNA expression following a single challenge with DOI. These functional changes were not associated with changes in 5‐HT2AR binding. Also, binding of the 5‐HT1AR and the 5‐HT transporter was unaffected. Finally, basal mRNA level of Arc was increased in the prefrontal cortex after subchronic PCP administration as revealed with in situ hybridization. Together these findings indicate that PCP administration produces changes in the brain that result in an increase in the absolute effect of DOI. Therefore, neurotransmission involving the 5‐HT2AR could contribute to the behavioral deficits observed after PCP treatment. © 2013 Wiley Periodicals, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>23404493</pmid><doi>10.1002/jnr.23198</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0360-4012 |
ispartof | Journal of neuroscience research, 2013-05, Vol.91 (5), p.634-641 |
issn | 0360-4012 1097-4547 |
language | eng |
recordid | cdi_proquest_miscellaneous_1434033394 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | AIDS-Related Complex - genetics AIDS-Related Complex - metabolism Amphetamines - pharmacology Analysis of Variance Animals Autoradiography Disease Models, Animal Gene Expression Regulation - drug effects Gene Expression Regulation - physiology Genes, Immediate-Early - genetics immediate early genes Male Mice Mice, Inbred C57BL N-methyl-D-aspartate Phencyclidine - pharmacology Phencyclidine - toxicity prefrontal cortex Prefrontal Cortex - drug effects Prefrontal Cortex - metabolism Proto-Oncogene Proteins c-fos - genetics Proto-Oncogene Proteins c-fos - metabolism Receptors, Serotonin, 5-HT2 - metabolism RNA, Messenger - metabolism schizophrenia Schizophrenia - chemically induced Schizophrenia - pathology Serotonin Receptor Agonists - pharmacology serotoninergic receptors Signal Transduction - drug effects Time Factors |
title | Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T12%3A42%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhanced%20prefrontal%20serotonin%202A%20receptor%20signaling%20in%20the%20subchronic%20phencyclidine%20mouse%20model%20of%20schizophrenia&rft.jtitle=Journal%20of%20neuroscience%20research&rft.au=Santini,%20Martin%20A.&rft.date=2013-05&rft.volume=91&rft.issue=5&rft.spage=634&rft.epage=641&rft.pages=634-641&rft.issn=0360-4012&rft.eissn=1097-4547&rft_id=info:doi/10.1002/jnr.23198&rft_dat=%3Cproquest_cross%3E1434033394%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4248-ab6353dbc113c4a9a06802201c042b6c623b43008953580d560aaaac03d1dae43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1317498351&rft_id=info:pmid/23404493&rfr_iscdi=true |